Advances in clinical pulmonology are transforming the diagnosis, management, and long-term outcomes of patients with complex respiratory conditions. With an increasing burden of chronic respiratory diseases globally, clinical decision-making now demands integration of precision diagnostics, phenotype-specific therapies, and real-time monitoring tools. The role of multidisciplinary care is expanding, especially in managing conditions like pulmonary hypertension, interstitial lung diseases, and acute respiratory distress syndrome. Recent studies have emphasized the significance of early intervention strategies and individualized treatment protocols based on disease progression markers. The emergence of digital health tools, such as remote spirometry and AI-assisted radiologic analysis, is further refining clinical workflows. In addition, updated global guidelines for obstructive and restrictive lung diseases underscore a more nuanced approach to pharmacologic regimens and rehabilitation. Clinical Pulmonology stands at a pivotal intersection of evidence-based medicine, patient-centered care, and technological evolution—driving the next phase of respiratory healthcare delivery.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation